🇺🇸 FDA
Company

Summit

Summit Therapeutics

SMMT pharma USA

Quick answer

Summit is a pharma company (SMMT) headquartered in MIAMI, FL, USA with 24 tracked pipeline programs.

Pipeline (24)

project

AK112 Injection

Non-Squamous Non-small Cell Lung Cancer

Phase 3 · small_molecule · active

1 trials project

Acupuncture

Fatigue

Phase 3 · other · active

1 trials project

Drug: Ivonescimab Injection

Metastatic Colorectal Cancer (CRC)

Phase 3 · small_molecule · active

1 trials project

Ivonescimab 10 mg/kg

Squamous Cell Carcinoma Head and Neck Cancer (HNSCC)

Phase 3 · small_molecule · active

1 trials project

Ivonescimab Injection

Non-Small Cell Lung Cancer

Phase 3 · mab · active

2 trials project

Ridinilazole

Clostridioides Difficile Infection

Phase 3 · small_molecule · completed

2 trials project

AK112

Metastatic Colorectal Cancer

Phase 2 · small_molecule · active

1 trials project

Ezutromid

Duchenne Muscular Dystrophy

Phase 2 · small_molecule · terminated

1 trials project

Hyperbaric Oxygen Therapy

TBI Traumatic Brain Injury

Phase 2 · small_molecule · active

1 trials project

Ivonescimab

Leiomyosarcoma

Phase 2 · small_molecule · active

1 trials project

Ivonescimab

Cutaneous Squamous Cell Carcinoma

Phase 2 · small_molecule · active

1 trials project

Ivonescimab

Endometrial Cancer

Phase 2 · small_molecule · active

1 trials project

Ivonescimab

Glioblastoma

Phase 2 · small_molecule · active

1 trials project

Ivonescimab

Ivonescimab

Phase 2 · small_molecule · active

1 trials project

Ivonescimab

Lung Cancer (NSCLC)

Phase 2 · small_molecule · active

1 trials project

Ivonescimab

Metastatic Colorectal Cancer

Phase 2 · small_molecule · active

2 trials project

Ivonescimab

Metastatic Esophageal Adenocarcinoma

Phase 2 · small_molecule · active

1 trials project

Ivonescimab

Non-Small Cell Lung Cancer

Phase 2 · small_molecule · active

3 trials project

Ivonescimab

Pleural Mesotheliomas

Phase 2 · small_molecule · active

1 trials project

Ivonescimab

Salivary Gland Cancer

Phase 2 · small_molecule · active

1 trials project

Ivonescimab

Stomach Cancer Stage IV

Phase 2 · small_molecule · active

1 trials project

Ivonescimab

Thymus Carcinoma

Phase 2 · mab · active

1 trials project

Ivonescimab

TNBC

Phase 2 · small_molecule · active

1 trials project

Ivonescimab

Advanced Head and Neck Squamous Cell Carcinoma

Phase 2 · mab · active

1 trials

Patents (8)

patent

US 12318487

Solid tablet dosage form of ridinilazole

Expires Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11344575

Vascular calcification prevention and treatment

Expires Mon May 26 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11007171

Treatment and prevention of joint disorders

Expires Mon May 13 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 9763925

Antibacterial compounds

Expires Mon Sep 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 9492433

Pharmaceutical composition for the treatment of Duchenne muscular dystrophy

Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 9314456

Antibacterial compounds

Expires Mon Apr 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 9278091

Compounds for the treatment of Clostridium difficile associated disease

Expires Mon Mar 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 8987308

Compounds for the treatment of Clostridium difficile-associated disease

Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)